Theralase is a leading company in personalized anti-cancer therapy and cool laser therapy, with a strong focus on improving the quality of life for cancer and pain patients. With a team of experts in various disciplines, including physics, engineering, medicine, and pharmaceutical drug design, Theralase is dedicated to driving the next level of technology in personalized healthcare. Founded in 1994, Theralase's operations are divided into two main divisions: the Cool Laser Therapy division, which develops and distributes medical laser technologies for pain relief, and the Anti-Cancer Therapy division, which combines photo dynamic compounds with medical laser technologies to effectively destroy cancer, bacteria, and viruses.
For over 25 years, Theralase has been committed to researching, developing, manufacturing, and distributing high-quality medical laser technologies to healthcare practitioners at an affordable price. Their team of scientists, medical professionals, and engineers conduct world-class preclinical and clinical research to ensure the effectiveness and safety of their products. With a mission to destroy cancer at the speed of light and heal pain at the speed of light, Theralase is at the forefront of innovative healthcare solutions.
Generated from the website